NEO:BGHC Holdings Information

NEO:BGHC is an equity ETF with a total of 37 individual holdings. The top holdings are Eli Lilly and Company stock at 9.53%, Boston Scientific at 6.64%, Johnson & Johnson at 6.54%, AstraZeneca at 5.79%, and AbbVie at 5.49%.

Total Holdings

Top 10 Percentage

53.83%

Asset Class

Equity

ETF Category

Health Care

Assets

7.86M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.53%	2,121
2	BSX	Boston Scientific Corporation	6.64%	16,391
3	JNJ	Johnson & Johnson	6.54%	6,640
4	LON: AZN	AstraZeneca PLC	5.79%	7,201
5	ABBV	AbbVie Inc.	5.49%	5,688
6	EBR: UCB	UCB SA	4.84%	3,692
7	SWX: ROG	Roche Holding AG	4.71%	2,399
8	TMO	Thermo Fisher Scientific Inc.	3.55%	1,415
9	UNH	UnitedHealth Group Incorporated	3.38%	2,716
10	n/a	Cash	3.36%	1
11	MCK	McKesson Corporation	3.35%	930
12	EBR: ARGX	argenx SE	3.34%	917
13	GILD	Gilead Sciences, Inc.	3.05%	4,963
14	ABT	Abbott Laboratories	2.85%	6,025
15	DHR	Danaher Corporation	2.58%	2,726
16	CI	The Cigna Group	2.54%	2,142
17	ISRG	Intuitive Surgical, Inc.	2.44%	1,117
18	VRTX	Vertex Pharmaceuticals Incorporated	2.33%	1,144
19	SWX: NOVN	Novartis AG	2.04%	3,168
20	BTSG	BrightSpring Health Services, Inc.	2.00%	11,741
21	DXCM	DexCom, Inc.	1.97%	6,238
22	SYK	Stryker Corporation	1.85%	1,155
23	REGN	Regeneron Pharmaceuticals, Inc.	1.75%	544
24	COGT	Cogent Biosciences, Inc.	1.64%	10,545
25	SWX: GALD	Galderma Group AG	1.61%	1,996

Showing 25 of 37 holdings

Subscribe to see the full list

Activate Now

As of Jan 30, 2026